| Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients. | |
| | |
MedLine Citation:
|
PMID: 7893846 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A number of previously published homogenate receptor binding studies have postulated that dopaminergic dysfunction in schizophrenia may be related to abnormalities in dopamine receptors. In this study, postmortem striatal specimens from patients with schizophrenia, normal controls, and psychiatric controls that had received neuroleptics were studied with quantitative autoradiography for dopamine receptors. Autoradiography with single concentrations of [3H]-SCH 23390 for D1 receptors, [3H]-raclopride for D2 receptors, and [3H]-CFT for dopamine uptake sites failed to define significant differences between the study groups. [3H]-CFT bound in a patchy distribution in the striatum that is believed to correspond to striosomal and matrix striatal compartments. There were no differences between groups when [3H]-CFT binding density was examined in the striosomal and matrix compartments. There were also no differences between groups in the percentage of striatal area occupied by striosomal or matrix compartments as defined by [3H]-CFT binding. We conclude that abnormalities of these dopamine receptor subtypes are probably not primary features of the schizophrenic syndrome in the brain collection examined. Previous reports of elevated D2 receptor binding in schizophrenia may have been related to drug treatment effects. Alternatively, the relatively high affinity of ligands used in previous studies for D4 receptors may explain the discrepancy in our findings. Unchanged [3H]-CFT binding in the schizophrenic group also suggests that the density of mesostriatal neuronal terminals is not altered in schizophrenia. |
| | |
Authors:
|
M B Knable; T M Hyde; M M Herman; J M Carter; L Bigelow; J E Kleinman |
Related Documents
:
|
7675236 - Positron emission tomography study of human narcolepsy: no increase in striatal dopamin... 1825226 - Effects of spiperone, raclopride, sch 23390 and clozapine on apomorphine inhibition of ... 2957716 - Pet analysis of human dopamine receptor subtypes using 11c-sch 23390 and 11c-raclopride. 17586476 - Estimation of baseline dopamine d2 receptor occupancy in striatum and extrastriatal reg... 2891546 - Bradykinin receptor antagonists used to characterize the heterogeneity of bradykinin-in... 7797576 - Enhancement of the binding of triglyceride-rich lipoproteins to the very low density li... |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Biological psychiatry Volume: 36 ISSN: 0006-3223 ISO Abbreviation: Biol. Psychiatry Publication Date: 1994 Dec |
Date Detail:
|
Created Date: 1995-04-26 Completed Date: 1995-04-26 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 0213264 Medline TA: Biol Psychiatry Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 827-35 Citation Subset: IM |
Affiliation:
|
National Institute of Mental Health, Clinical Brain Disorders Branch, Washington, D.C. 20032. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Autoradiography* Benzazepines / therapeutic use Binding Sites Cell Count Corpus Striatum / chemistry*, metabolism* Culture Techniques Humans Raclopride Receptors, Dopamine D1 / analysis*, metabolism* Receptors, Dopamine D2 / analysis*, metabolism* Salicylamides / diagnostic use Schizophrenia / metabolism*, physiopathology* |
| Chemical | |
Reg. No./Substance:
|
0/Benzazepines; 0/Receptors, Dopamine D1; 0/Receptors, Dopamine D2; 0/Salicylamides; 84225-95-6/Raclopride |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Quantitative electrophysiological characteristics and subtyping of schizophrenia.
Next Document: Role of interleukin-6 and transforming growth factor-beta in anorexia nervosa.